LISTED digital medicines management company MedAdvisor and healthcare services group Zuellig Pharma have announced they have finalised the formation of a Singapore based 50:50 joint venture establishing a new entity called ZP MedAdvisor Pte Ltd (ZPM).
Zuellig Pharma's $US13 billion business provides healthcare services to over 350,000 medical facilities (pharmacies, medical clinics, hospitals) across Asia, and works with more than 1,000 clients, including the top 20 pharmaceutical companies in the world.
The new entity, ZPM, will see the MedAdvisor software licensed to the JV so it has exclusive access to the medication management products and technology solutions for eight markets in the Asia region.
Under the agreement, Zuellig Pharma will market to its network of pharmacies, medical clinics and its top 20 global pharmaceutical manufacturer clients.
Additionally, Zuellig Pharma will work with existing manufacturer clientele to run adherence programs through ZPM.
ZPM's initial launch efforts are to be focused on the Philippines and Malaysia with other markets identified for subsequent rollout.
MedAdvisor CEO Robert Read commented: "I am delighted that the initial formation of our joint venture with Zuellig Pharma has been completed.
"The strong partnership is based on a shared purpose to improve patient health.
"MedAdvisor's global technology platform combined with Zuellig Pharma's network and client reach will be a formidable combination and the formation of this joint venture with a company of Zuellig Pharma's size, reach and reputation represents a strong validation of MedAdvisor's global reputation as a leader in its field."
John Davison, CEO of Zuellig Pharma, added his support and respect for the MedAdvisor systems.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 May 19
